Method and composition for treating bronchospastic airway diseases
US4689213A · kind A · utility
2Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 23, 1985 |
| Grant date | Aug 25, 1987 |
| Priority date | — |
| Expiry date | Oct 23, 2005 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/275
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Bronchospastic diseases characterized by airway hyperreactivity are treated by administration of the calcium channel blocker gallopamil. Unlike other calcium channel blockers, the effective dose of gallopamil is small enough that undesirable side effects are not present.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.